News
Investors reacted negatively to the news. The company’s stock fell more than 16% yesterday. It’s also a setback in ...
Pharmaceutical Technology on MSN1d
Recursion axes drug programmes to streamline pipelineAI business Recursion Pharmaceuticals has narrowed its drug development pipeline, ending or pausing five programmes as it ...
2don MSN
Q1 2025 Management View CEO Chris Gibson highlighted the company's strategic focus on the Recursion Operating System 2.0, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback